Endothelial cell and T-cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation

49Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The role of metabolic reprogramming in the coordination of the immune response has gained increasing consideration in recent years. Indeed, it has become clear that changes in the metabolic status of immune cells can alter their functional properties. During inflammation, T cells need to generate sufficient energy and biomolecules to support growth, proliferation, and effector functions. Therefore, T cells need to rearrange their metabolism to meet these demands. A similar metabolic reprogramming has been described in endothelial cells, which have the ability to interact with and modulate the function of immune cells. In this overview, we will discuss recent insights in the complex crosstalk between endothelial cells and T cells as well as their metabolic reprogramming following activation. We highlight key components of this metabolic switch that can lead to the development of new therapeutics against chronic inflammatory disorders. LINKED ARTICLES: This article is part of a themed issue on Cellular metabolism and diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.10/issuetoc.

Cite

CITATION STYLE

APA

Certo, M., Elkafrawy, H., Pucino, V., Cucchi, D., Cheung, K. C. P., & Mauro, C. (2021, May 1). Endothelial cell and T-cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation. British Journal of Pharmacology. John Wiley and Sons Inc. https://doi.org/10.1111/bph.15002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free